Indo US Bio-Tech Ltd - Stock Valuation and Financial Performance

BSE: 541304 | NSE: INDOUS | Agriculture | Small Cap

Indo US Bio-Tech Share Price

314.85 -16.60 -5.01%
as on 20-Dec'24 16:59

DeciZen - make an informed investing decision on Indo US Bio-Tech

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Indo US Bio-Tech stock performance -

mw4me loader
P/E Ratio (SA):
53.79
Market Cap:
631.3 Cr.
52-wk low:
180
52-wk high:
386

Is Indo US Bio-Tech Ltd an attractive stock to invest in?

1. Is Indo US Bio-Tech Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Indo US Bio-Tech Ltd is a average quality company.

2. Is Indo US Bio-Tech Ltd undervalued or overvalued?

The key valuation ratios of Indo US Bio-Tech Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Indo US Bio-Tech Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Indo US Bio-Tech Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

10 Year X-Ray of Indo US Bio-Tech:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Indo US Bio-Tech Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 13.9%7.4%14.2%27.8%20.4%16.7%18.3%15.9%14.6%14.4%-
Value Creation
Index
0.0-0.50.01.00.50.20.30.10.00.0-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 19.619.124.529.635.539.840.150.161.772.885
Sales YoY Gr.--2.7%28.7%20.9%19.8%12%0.8%24.8%23.4%18%-
Adj EPS 0.50.40.41.51.51.83.52.93.64.15.9
YoY Gr.--27.1%11.4%292.3%-1.3%15.9%100%-18.3%26.2%14.1%-
BVPS (₹) 2.83.23.44.89.511.314.821.227.231.335
Adj Net
Profit
0.50.40.41.62.22.65.15.27.28.312
Cash Flow from Ops. 0.1-2.60.1-0.9-3.2-0.80.22.90.5-4.6-
Debt/CF from Ops. 11.7-1.871.5-7.4-2-10.2514.322.1-3.1-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 15.7%15.5%22%18%
Adj EPS 27%22.2%5.6%14.1%
BVPS30.7%26.9%28.4%15.1%
Share Price - 61% 102.4% 31.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
19.811.711.737.223.316.826.917.315.514.117.6
Op. Profit
Mgn %
3.12.75.19.710.11013.813.915.214.816.5
Net Profit
Mgn %
2.51.91.65.36.26.412.710.511.711.313.8
Debt to
Equity
0.61.41.41.30.50.50.50.30.20.20
Working Cap
Days
101173170161188243322314317331182
Cash Conv.
Cycle
488484102146173214255271295143

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 17.60%

Sales growth is growing at healthy rate in last 3 years 22.02%

Sales growth is good in last 4 quarters at 24.78%

Net Profit has been subdued in last 3 years 5.59%

Latest Financials - Indo US Bio-Tech Ltd.

Standalone Consolidated
TTM EPS (₹) 5.9 2.5
TTM Sales (₹ Cr.) 84.8 50.1
BVPS (₹.) 35 0
Reserves (₹ Cr.) 50 29
P/BV 8.99 0.00
PE 53.79 124.69
From the Market
52 Week Low / High (₹) 180.00 / 386.00
All Time Low / High (₹) 12.85 / 386.00
Market Cap (₹ Cr.) 631
Equity (₹ Cr.) 20.1
Face Value (₹) 10
Industry PE 42.2

Management X-Ray of Indo US Bio-Tech:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Indo US Bio-Tech

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales20192530354040506273
Operating Expenses 19192327323635435262
Manufacturing Costs110272929484677
Material Costs171720232240-92-20
Employee Cost 0000000011
Other Costs 1122225433
Operating Profit 11133467911
Operating Profit Margin (%) 3.1%2.7%5.1%9.1%9.6%10.0%13.8%13.8%15.2%14.8%
Other Income 0000000000
Interest 0011011112
Depreciation 0000000011
Exceptional Items 0000000000
Profit Before Tax 0012334579
Tax 000110-1001
Profit After Tax 0001235578
PAT Margin (%) 2.5%1.9%1.6%4.9%5.9%6.4%12.7%10.5%11.7%11.3%
Adjusted EPS (₹)0.50.40.41.41.41.73.52.93.64.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 3335141622395463
Share Capital 111356691020
Reserves 122291015304443
Minority Interest0000000000
Debt25565811101013
Long Term Debt0001113323
Short Term Debt14455777810
Trade Payables3545289214
Others Liabilities 0001222433
Total Liabilities 7131217243543556984

Fixed Assets

Gross Block2222312677
Accumulated Depreciation1110100000
Net Fixed Assets1112112677
CWIP 0000112214
Investments 0000000000
Inventories455611912232752
Trade Receivables165992125212519
Cash Equivalents 0000000001
Others Assets1110122381
Total Assets 7131217243543556984

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 0-30-1-3-1031-5
PBT 0012334579
Adjustment 0001111222
Changes in Working Capital -1-3-1-3-7-5-5-4-9-15
Tax Paid 0000000000
Cash Flow From Investing Activity 0000-3-1-2-5-74
Capex 0000-10-2-4-2-3
Net Investments 0000000000
Others 0001-100-1-57
Cash Flow From Financing Activity 0301621261
Net Proceeds from Shares 0000700380
Net Proceeds from Borrowing 0001-1030-21
Interest Paid 000-10-1-1-1-1-2
Dividend Paid 0000000000
Others 0300030112
Net Cash Flow 0000000001
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)19.8311.6911.7434.3622.2116.7426.8717.3415.5114.08
ROCE (%)13.927.3914.2427.8420.3516.6518.315.8614.6214.42
Asset Turnover Ratio3.011.881.952.051.741.361.031.0210.95
PAT to CFO Conversion(x)N/AN/AN/A-1-1.5-0.3300.60.14-0.63
Working Capital Days
Receivable Days3166798793138208165134110
Inventory Days58917870879196128149197
Payable Days47867964544180-223302-54

Indo US Bio-Tech Ltd Stock News

Indo US Bio-Tech Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Indo US Bio-Tech on 20-Dec-2024 16:59 is ₹314.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Indo US Bio-Tech stood at ₹631.3.
The latest P/E ratio of Indo US Bio-Tech as of 20-Dec-2024 16:59 is 53.79.
The latest P/B ratio of Indo US Bio-Tech as of 20-Dec-2024 16:59 is 8.99.
The 52-week high of Indo US Bio-Tech is ₹386.0 and the 52-week low is ₹180.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Indo US Bio-Tech is ₹84.77 ( Cr.) .

About Indo US Bio-Tech Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.